Jane Fogarty
Known title: EVP, LegalCIK: 0001884030
Jane Fogarty's purchase track record
How the stock did after each of Jane Fogarty's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
7
of 7 since April 26, 2022
Stock higher 6 months later
29%
3 months: 43%
Median 6-month return
-21.1%
3 months: -2.4%
Beat the S&P 500
29%
median -18.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/3/2024 | CNXC | $24K | +15.4% | -9.2% | +9.6% |
| 1/30/2024 | CNXC | $18K | -38.6% | -21.1% | +10.4% |
| 10/23/2023 | CNXC | $15K | +33.3% | -27.7% | +18.8% |
| 10/5/2023 | CNXC | $16K | +23.6% | -23.4% | +20.9% |
| 7/5/2023 | CNXC | $33K | -2.4% | +19.0% | +5.8% |
| 7/29/2022 | CNXC | $54K | -8.4% | +4.3% | -1.5% |
| 4/26/2022 | CNXC | $40K | -15.6% | -21.3% | -7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CNXC | ▼ Sell | Tax Withholding | 563 | $21K | 2/1/2026 | View on chart |
| CNXC | ▲ Buy | Grant | 220 | $0 | 1/28/2026 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 79 | $3K | 1/28/2026 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 168 | $7K | 1/27/2026 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 105 | $4K | 1/26/2026 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 1,319 | $57K | 1/24/2026 | View on chart |
| CNXC | ▲ Buy | Grant | 13,913 | $0 | 1/21/2026 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 126 | $6K | 10/5/2025 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 638 | $33K | 2/1/2025 | View on chart |
| CNXC | ▲ Buy | Grant | 384 | $0 | 1/29/2025 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 158 | $9K | 1/29/2025 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 194 | $10K | 1/27/2025 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 114 | $6K | 1/26/2025 | View on chart |
| CNXC | ▲ Buy | Grant | 9,611 | $0 | 1/24/2025 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 126 | $7K | 10/5/2024 | View on chart |
| CNXC | ▲ Buy | Open Market | 400 | $24K | 4/3/2024 | View on chart |
| CNXC | ▲ Buy | Grant | 4,704 | $0 | 2/1/2024 | View on chart |
| CNXC | ▲ Buy | Open Market | 200 | $18K | 1/30/2024 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 194 | $18K | 1/27/2024 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 113 | $10K | 1/26/2024 | View on chart |
| CNXC | ▲ Buy | Open Market | 200 | $15K | 10/23/2023 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 122 | $10K | 10/5/2023 | View on chart |
| CNXC | ▲ Buy | Open Market | 200 | $16K | 10/5/2023 | View on chart |
| CNXC | ▲ Buy | Open Market | 400 | $33K | 7/5/2023 | View on chart |
| CNXC | ▲ Buy | Grant | 1,888 | $0 | 1/27/2023 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 113 | $16K | 1/26/2023 | View on chart |
| CNXC | ▼ Sell | Tax Withholding | 122 | $15K | 10/5/2022 | View on chart |
| CNXC | ▲ Buy | Open Market | 400 | $54K | 7/29/2022 | View on chart |
| CNXC | ▲ Buy | Open Market | 258 | $40K | 4/26/2022 | View on chart |
| CNXC | ▲ Buy | Grant | 1,102 | $0 | 1/26/2022 | View on chart |
| CNXC | ▲ Buy | Grant | 1,404 | $0 | 10/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
CNXC Faces Scrutiny Over Loss Guidance and Dividend Policy
Recent articles question whether Concentrix's loss-making guidance and ongoing dividend payouts are changing its investment case. The stock is also being highlighted in broader business services industry outlooks alongside peers like ABM and Sodexo. With the share price trading near its 52-week low, these reports add context to the current valuation debate.
CNXC Faces Scrutiny Over Loss Guidance and Dividend Policy. Recent articles question whether Concentrix's loss-making guidance and ongoing dividend payouts are changing its investment case. The stock is also being highlighted in broader business services industry outlooks alongside peers like ABM and Sodexo. With the share price trading near its 52-week low, these reports add context to the current valuation debate.